Details for Patent: 5,104,888

✉ Email this page to a colleague

Summary for Patent: 5,104,888

Title:	Thiazolidine derivatives, their preparation and use
Abstract:	Compounds of formula (I): ##STR1## (in which R.sup.1 -R.sup.7 are hydrogen or various organic groups, n is 1-10, Ar is an aromatic group, U is CH.sub.2 or a carbon atom doubly bonded to either one of its adjacent carbons, and W is >CH.sub.2, >C.dbd.O, >CHOH, >C.dbd.NOH or various derivatives thereof) have the ability to lower the levels of blood lipid peroxides and blood sugars and to inhibit the activity of aldose reductase; they may be used therapeutically for these purposes.
Inventor(s):	Yoshioka; Takao (Hiromachi, JP), Kitazawa; Eiichi (Hiromachi, JP), Kurumada; Yomoyuki (Hiromachi, JP), Yamazaki; Mitsuo (Hiromachi, JP), Hasegawa; Kazuo (Hiromachi, JP), Fujita; Takashi (Hiromachi, JP)
Assignee:	Sankyo Company, Limited (Tokyo, JP)
Application Number:	07/560,466
Patent Claim Types: see list of patent claims	Compound; Use; Composition;

Drugs Protected by US Patent 5,104,888

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,104,888

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	60-35324	Feb 26, 1985
Japan	60-35325	Feb 26, 1985

International Family Members for US Patent 5,104,888

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	56448	⤷ Sign Up
Australia	5412286	⤷ Sign Up
Australia	588857	⤷ Sign Up
Canada	1256106	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.